Akèy › Maladi Crohn › Georgia › Atlanta
Etid klinik pou Maladi Crohn nan Atlanta, GA
17 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Atlanta (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Ap rekriteFaz 3
- Morehouse School Of Medicine ( Site 5071), Atlanta
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Ap rekriteFaz 4
- Digestive Healthcare of Georgia, Atlanta
- AGA GA Research LLC, Atlanta
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Emory University, Atlanta
- Children's Center for Digestive Health Care, Atlanta
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Morehouse School of Medicine, Atlanta
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2/3
- Emory University, Atlanta
- Children's Center for Digestive Health Care, Atlanta
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Ap rekriteFaz 3
- Emory University, Atlanta
- Children's Center for Digestive Healthcare, Atlanta
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2
- Emory University Hospital, The Emory Clinic, Atlanta
- Atlanta Center For Gastroenterology, P.C., Decatur · 6 mi lwen
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Atlanta Gastroenterology Associates-Site Number: 8400109, Atlanta
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2
- Atlanta Gastroenterology Specialists, PC, Atlanta
- Atlanta Gastroenterology Associates (Part of United Digestive), Atlanta
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Ap rekriteFaz 2
- Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Ap rekriteFaz 3
- Emory University School of Medicine, Atlanta
- Children's Center for Digestive Health Care, LLC, Atlanta
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Ap rekriteFaz 2
- Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Ap rekriteFaz 3
- Emory University, Atlanta
- Children's Center for Digestive Health Care, LLC, Atlanta
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Ap rekriteFaz 4
- Emory University, Atlanta
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ap rekriteFaz 3
- Childrens Center For Digestive Healthcare, Atlanta
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Ap rekriteFaz 3
- Childrens Center For Digestive Healthcare, Atlanta
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Ap rekriteFaz 2
- Mirador Therapeutics Selected Site, Atlanta
Etid Maladi Crohn nan lòt vil
- New York City, NY35 etid
- Cleveland, OH19 etid
- St. Louis, MO19 etid
- Boston, MA19 etid
- Miami, FL19 etid
- Orlando, FL17 etid
- Houston, TX17 etid
- Tyler, TX16 etid
- San Diego, CA15 etid
- San Antonio, TX15 etid
- Los Angeles, CA15 etid
- Philadelphia, PA13 etid
Lòt etid nan Atlanta
- Kansè (tout kalite)49 etid
- Kansè Poumon ki pa ti selil47 etid
- Kansè nan tete41 etid
- Myelom Miltip41 etid
- Kansè pwostat33 etid
- Leksemi mieloïd egi30 etid
- Kansè ovè29 etid
- Kansè poumon29 etid
- Kansè kolorektal29 etid
- Kansè Metastatik28 etid
- Ensifizyans kadyak25 etid
- Twoub depresif majè25 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.